SphingoTec
PrivateLast Round
Series C
Aug 8, 2024
Total Funding Raised
$28.55M
Company Overview
SphingoTec is a diagnostics company that develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, prediction and monitoring of acute medical conditions.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SphingoTec Comps
Public and private peers based on sector, stage, and business model.
SphingoTec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 8, 2024 | ||||
| VC Round | Feb 21, 2024 | ||||
| Growth Equity | Oct 8, 2018 |
SphingoTec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Think.Health | Series C |
| HBM Healthcare Investments | Series C, Growth Equity |
| NRW.Bank | Series C |
| Brandenburg Kapital | Series C |
| Wellington Partners | Series C, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 8, 2024
$5.55M round led by Think.Health.
- Feb 21, 2024
Completed a VC Round fundraise.
SphingoTec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SphingoTec's valuation, stock price, and market status.
